451 related articles for article (PubMed ID: 31076418)
21. A prospective study of multiple protein biomarkers to predict progression in diabetic chronic kidney disease.
Agarwal R; Duffin KL; Laska DA; Voelker JR; Breyer MD; Mitchell PG
Nephrol Dial Transplant; 2014 Dec; 29(12):2293-302. PubMed ID: 25085239
[TBL] [Abstract][Full Text] [Related]
22. Implications of immunoglobulin G deposit in glomeruli in Chinese patients with diabetic nephropathy.
Zhang J; Zhang J; Zhang R; Wang Y; Liang Y; Yang Z; Wang T; Xu X; Liu F
J Diabetes; 2020 Jul; 12(7):521-531. PubMed ID: 32031751
[TBL] [Abstract][Full Text] [Related]
23. Clinical and pathological predictors of estimated GFR decline in patients with type 2 diabetes and overt proteinuric diabetic nephropathy.
Mise K; Hoshino J; Ueno T; Hazue R; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Fujii T; Hara S; Ohashi K; Takaichi K; Ubara Y
Diabetes Metab Res Rev; 2015 Sep; 31(6):572-81. PubMed ID: 25533683
[TBL] [Abstract][Full Text] [Related]
24. Increased indoleamine 2,3-dioxygenase activity in type 2 diabetic nephropathy.
Zhang Y; Ruan Y; Zhang P; Wang L
J Diabetes Complications; 2017 Jan; 31(1):223-227. PubMed ID: 27646613
[TBL] [Abstract][Full Text] [Related]
25. Biomarkers for early diagnosis of type 2 diabetic nephropathy: a study based on an integrated biomarker system.
Huang M; Liang Q; Li P; Xia J; Wang Y; Hu P; Jiang Z; He Y; Pang L; Han L; Wang Y; Luo G
Mol Biosyst; 2013 Aug; 9(8):2134-41. PubMed ID: 23719966
[TBL] [Abstract][Full Text] [Related]
26. Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol.
Gooding KM; Lienczewski C; Papale M; Koivuviita N; Maziarz M; Dutius Andersson AM; Sharma K; Pontrelli P; Garcia Hernandez A; Bailey J; Tobin K; Saunavaara V; Zetterqvist A; Shelley D; Teh I; Ball C; Puppala S; Ibberson M; Karihaloo A; Metsärinne K; Banks RE; Gilmour PS; Mansfield M; Gilchrist M; de Zeeuw D; Heerspink HJL; Nuutila P; Kretzler M; Welberry Smith M; Gesualdo L; Andress D; Grenier N; Shore AC; Gomez MF; Sourbron S;
BMC Nephrol; 2020 Jun; 21(1):242. PubMed ID: 32600374
[TBL] [Abstract][Full Text] [Related]
27. Validating the association between plasma tumour necrosis factor receptor 1 levels and the presence of renal injury and functional decline in patients with Type 2 diabetes.
Doody A; Jackson S; Elliott JA; Canavan RJ; Godson C; Slattery D; Twomey PJ; McKenna MJ; le Roux CW; Docherty NG
J Diabetes Complications; 2018 Jan; 32(1):95-99. PubMed ID: 29122448
[TBL] [Abstract][Full Text] [Related]
28. Are glomerular volume differences between type 1 and type 2 diabetic patients pathologically significant?
White KE; Marshall SM; Bilous RW
Diabetologia; 2007 May; 50(5):906-12. PubMed ID: 17333103
[TBL] [Abstract][Full Text] [Related]
29. Sexual dimorphism in the progression of type 2 diabetic kidney disease in T2DN rats.
Spires DR; Palygin O; Levchenko V; Isaeva E; Klemens CA; Khedr S; Nikolaienko O; Kriegel A; Cheng X; Yeo JY; Joe B; Staruschenko A
Physiol Genomics; 2021 Jun; 53(6):223-234. PubMed ID: 33870721
[TBL] [Abstract][Full Text] [Related]
30. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease.
Niewczas MA; Mathew AV; Croall S; Byun J; Major M; Sabisetti VS; Smiles A; Bonventre JV; Pennathur S; Krolewski AS
Diabetes Care; 2017 Mar; 40(3):383-390. PubMed ID: 28087576
[TBL] [Abstract][Full Text] [Related]
31. Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus.
Penno G; Russo E; Garofolo M; Daniele G; Lucchesi D; Giusti L; Sancho Bornez V; Bianchi C; Dardano A; Miccoli R; Del Prato S
Diabetologia; 2017 Jun; 60(6):1102-1113. PubMed ID: 28357502
[TBL] [Abstract][Full Text] [Related]
32. Increased levels of inflammatory mediators and proinflammatory monocytes in patients with type I diabetes mellitus and nephropathy.
Kolseth IB; Reine TM; Parker K; Sudworth A; Witczak BJ; Jenssen TG; Kolset SO
J Diabetes Complications; 2017 Jan; 31(1):245-252. PubMed ID: 27452162
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of atubular glomeruli in type 2 diabetic patients with nephropathy.
White KE; Marshall SM; Bilous RW
Nephrol Dial Transplant; 2008 Nov; 23(11):3539-45. PubMed ID: 18558622
[TBL] [Abstract][Full Text] [Related]
34. [Therapy of diabetes mellitus in patients with chronic kidney disease].
Bojunga J; Mondorf A
Dtsch Med Wochenschr; 2019 Aug; 144(15):1044-1050. PubMed ID: 31350746
[TBL] [Abstract][Full Text] [Related]
35. Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease.
Nkuipou-Kenfack E; Duranton F; Gayrard N; Argilés À; Lundin U; Weinberger KM; Dakna M; Delles C; Mullen W; Husi H; Klein J; Koeck T; Zürbig P; Mischak H
PLoS One; 2014; 9(5):e96955. PubMed ID: 24817014
[TBL] [Abstract][Full Text] [Related]
36. Circulating Levels of Soluble Klotho and Fibroblast Growth Factor 23 in Diabetic Patients and Its Association with Early Nephropathy.
Farías-Basulto A; Martínez-Ramírez HR; Gómez-García EF; Cueto-Manzano AM; Cortés-Sanabria L; Hernández-Ramos LE; Ramírez-López G; Mendoza-Carrera F
Arch Med Res; 2018 Oct; 49(7):451-455. PubMed ID: 30718148
[TBL] [Abstract][Full Text] [Related]
37. Plasma Leucine-Rich α-2-Glycoprotein 1 Predicts Rapid eGFR Decline and Albuminuria Progression in Type 2 Diabetes Mellitus.
Liu JJ; Pek SLT; Ang K; Tavintharan S; Lim SC;
J Clin Endocrinol Metab; 2017 Oct; 102(10):3683-3691. PubMed ID: 28973352
[TBL] [Abstract][Full Text] [Related]
38. Renoprotective effects of canagliflozin, a sodium glucose cotransporter 2 inhibitor, in type 2 diabetes patients with chronic kidney disease: A randomized open-label prospective trial.
Takashima H; Yoshida Y; Nagura C; Furukawa T; Tei R; Maruyama T; Maruyama N; Abe M
Diab Vasc Dis Res; 2018 Sep; 15(5):469-472. PubMed ID: 29923427
[TBL] [Abstract][Full Text] [Related]
39. Automated image analysis of a glomerular injury marker desmin in spontaneously diabetic Torii rats treated with losartan.
Kakimoto T; Okada K; Hirohashi Y; Relator R; Kawai M; Iguchi T; Fujitaka K; Nishio M; Kato T; Fukunari A; Utsumi H
J Endocrinol; 2014 Jul; 222(1):43-51. PubMed ID: 24781258
[TBL] [Abstract][Full Text] [Related]
40. Renal distribution of ganglioside GM3 in rat models of types 1 and 2 diabetes.
Novak A; Režić Mužinić N; Cikeš Čulić V; Božić J; Tičinović Kurir T; Ferhatović L; Puljak L; Markotić A
J Physiol Biochem; 2013 Dec; 69(4):727-35. PubMed ID: 23564406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
